ResearcherWeizmann Institute of ScienceActive in the last 2 years

Lucio Frydman

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0001-8208-3521; OpenAlex author ID A5071742208.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

Assessing the treatment of pancreatic ductal adenocarcinoma by deuterium metabolic imaging: a preclinical study. Last author DOI 10.1007/s10334-026-01340-z ↗
Improving deuterium metabolic imaging (DMI) signal-to-noise ratio by spectroscopic multi-echo bSSFP: A pancreatic cancer investigation. Last author DOI 10.1002/mrm.28906 ↗
Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models. Last author DOI 10.1002/nbm.4569 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Elton Tadeu Montrazi · 1 shared paper, 2026
- Paper Assessing the treatment of pancreatic ductal adenocarcinoma by deuterium metabolic imaging: a preclinical study. DOI 10.1007/s10334-026-01340-z ↗
Stefan Marković · 2 shared papers, 2021
- Paper Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models. DOI 10.1002/nbm.4569 ↗
- Paper Improving deuterium metabolic imaging (DMI) signal-to-noise ratio by spectroscopic multi-echo bSSFP: A pancreatic cance… DOI 10.1002/mrm.28906 ↗
Dana C. Peters · 1 shared paper, 2021
- Paper Improving deuterium metabolic imaging (DMI) signal-to-noise ratio by spectroscopic multi-echo bSSFP: A pancreatic cance… DOI 10.1002/mrm.28906 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.